Report cover image

Global Infectious Disease Molecular Diagnostics Market Size Study, By Product (Instruments, Reagents), By Technology (Mass Spectrometry, PCR, In Situ Hybridization), By Application, By End-Use, and Regional Forecasts 2024-2034

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464158

Description

The Global Infectious Disease Molecular Diagnostics Market is valued at approximately USD 54.03 billion in 2024 and is anticipated to grow with a CAGR of 4.1% over the forecast period 2025-2034. The increasing prevalence of infectious diseases worldwide, coupled with advancements in molecular diagnostic technologies, is propelling market growth. The growing demand for rapid and accurate disease detection methods, particularly in the wake of emerging infectious threats, has fueled investments in next-generation sequencing (NGS), polymerase chain reaction (PCR), and CRISPR-based diagnostic platforms. Additionally, technological innovations have significantly improved the precision, speed, and accessibility of diagnostic tests, enabling healthcare providers to make data-driven treatment decisions.

The rising incidence of diseases such as tuberculosis, hepatitis, sexually transmitted infections (STIs), respiratory illnesses, and antimicrobial-resistant infections has accelerated the adoption of molecular diagnostics. Government and private sector funding for infectious disease research, clinical trials, and innovative diagnostic tools are further amplifying market expansion. For instance, in January 2025, Rhode Island Hospital secured a USD 1 million grant from CARB-X to develop a direct-from-blood PCR test for pneumonia-causing bacteria. Similarly, Kryptos Biotechnologies received USD 1.2 million in funding to advance its rapid multiplex molecular diagnostic technology for STIs. These initiatives underscore the increasing focus on precision diagnostics to curb infectious disease outbreaks and improve patient outcomes.

Geographically, North America dominated the infectious disease molecular diagnostics market, accounting for a 40.95% revenue share in 2024. The region's strong foothold in diagnostic technologies, robust healthcare infrastructure, and high demand for rapid testing solutions contribute to its market leadership. The Asia-Pacific region is anticipated to witness the fastest CAGR over the forecast period, driven by rising disease prevalence, growing investments in diagnostic infrastructure, and increasing awareness about early disease detection. Countries such as China, India, and Japan are experiencing a surge in demand for molecular diagnostic tests due to their large patient populations, government funding for healthcare innovation, and advancements in home-based and point-of-care (PoC) testing solutions.

The growing adoption of artificial intelligence (AI) and digital health platforms in molecular diagnostics is expected to reshape the market landscape. AI-driven diagnostic tools enhance the accuracy and efficiency of pathogen detection, reducing false positives and improving diagnostic reliability. Additionally, cloud-based diagnostic platforms are streamlining real-time disease surveillance and outbreak management. With continued innovations in diagnostic technologies and increasing collaboration between public and private sector entities, the infectious disease molecular diagnostics market is poised for sustained growth throughout the forecast period.

Major Market Players Included in This Report Are:
  • Abbott
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc. (Gen-Probe)
  • Illumina, Inc.
  • Grifols S.A.
  • Qiagen
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • PerkinElmer, Inc.
The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Product:
  • Instruments
  • Reagents
  • Services
By Technology:
  • Polymerase Chain Reaction (PCR)
  • Multiplex PCR
  • Other PCR
  • In Situ Hybridization (ISH)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Transcription Mediated Amplification (TMA)
  • Others
By Application:
  • Respiratory Diseases
  • Tuberculosis
  • Meningitis
  • Gastrointestinal Tract Infections
  • Human Papillomavirus (HPV)
  • Sexually Transmitted Infections (STIs)
  • Sepsis
  • Drug-Resistant Diseases
  • Others
By End-Use:
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Research Institutes
By Region:

North America:
  • U.S.
  • Canada
  • Mexico
Europe:
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
Asia-Pacific:
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
Latin America:
  • Brazil
  • Argentina
Middle East & Africa (MEA):
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Years Considered for the Study Are as Follows:
  • Historical Year – 2022
  • Base Year – 2024
  • Forecast Period – 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 years (2022-2034).
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape, including country-level insights.
  • Competitive landscape featuring company profiles and strategic market positioning.
  • Analysis of key business strategies, including mergers, acquisitions, and technological innovations.
  • Demand-side and supply-side market analysis to highlight growth opportunities.

Table of Contents

285 Pages
Chapter 1. Global Infectious Disease Molecular Diagnostics Market Executive Summary
1.1. Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technology
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Infectious Disease Molecular Diagnostics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Infectious Disease Molecular Diagnostics Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Infectious Diseases Worldwide
3.1.2. Technological Advancements in Molecular Diagnostics
3.1.3. Growing Adoption of Point-of-Care Testing
3.2. Market Challenges
3.2.1. High Cost of Molecular Diagnostic Tests
3.2.2. Regulatory Hurdles and Stringent Approval Processes
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Increasing Focus on Personalized Medicine
Chapter 4. Global Infectious Disease Molecular Diagnostics Market Industry Analysis
4.1. Porter’s Five Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Force Model
4.1.7. Porter’s Five Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic Factors
4.2.3. Social Factors
4.2.4. Technological Factors
4.2.5. Environmental Factors
4.2.6. Legal Factors
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Product (2024-2034)
5.1. Segment Dashboard
5.2. Market Revenue Trend Analysis (USD Billion)
5.2.1. Instruments
5.2.2. Reagents
5.2.3. Services
Chapter 6. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Technology (2024-2034)
6.1. Segment Dashboard
6.2. Market Revenue Trend Analysis (USD Billion)
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. In Situ Hybridization
6.2.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.4. Chips and Microarrays
6.2.5. Mass Spectrometry
6.2.6. Transcription Mediated Amplification
6.2.7. Others
Chapter 7. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Application (2024-2034)
7.1. Segment Dashboard
7.2. Market Revenue Trend Analysis (USD Billion)
7.2.1. Respiratory Diseases
7.2.2. Tuberculosis
7.2.3. Meningitis
7.2.4. Gastrointestinal Tract Infections
7.2.5. Human Papillomavirus (HPV)
7.2.6. Sexually Transmitted Infections
7.2.7. Sepsis
7.2.8. Drug Resistance Diseases
7.2.9. Others
Chapter 8. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by End-Use (2024-2034)
8.1. Segment Dashboard
8.2. Market Revenue Trend Analysis (USD Billion)
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Diagnostic Laboratories
8.2.4. Research Institutes
Chapter 9. Global Infectious Disease Molecular Diagnostics Market Size & Forecasts by Region (2024-2034)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Denmark
9.2.7. Sweden
9.2.8. Norway
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Thailand
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
9.5.4. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Danaher Corporation
10.1.2. Abbott Laboratories
10.1.3. Roche Diagnostics
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott
10.3.2. Danaher Corporation
10.3.3. Bio-Rad Laboratories, Inc.
10.3.4. bioMérieux SA
10.3.5. F. Hoffmann-La Roche Ltd
10.3.6. Agilent Technologies, Inc.
10.3.7. Becton, Dickinson and Company
10.3.8. Hologic, Inc. (Gen-Probe)
10.3.9. Illumina, Inc.
10.3.10. Grifols S.A.
10.3.11. Qiagen
10.3.12. Siemens Healthineers AG
10.3.13. Sysmex Corporation
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us